Genomics, type 2 diabetes, and obesity.

@article{McCarthy2010GenomicsT2,
  title={Genomics, type 2 diabetes, and obesity.},
  author={Mark I. McCarthy},
  journal={The New England journal of medicine},
  year={2010},
  volume={363 24},
  pages={
          2339-50
        }
}
  • M. McCarthy
  • Published 8 December 2010
  • Medicine, Biology
  • The New England journal of medicine
The quickening pace of genetic discovery has resulted in the identification of more than 80 loci with proven roles in development of monogenic and multifactorial forms of nonautoimmune diabetes and obesity. 
View on PubMed
commed.vcu.edu
939 Citations
Highly Influential Citations
53
Background Citations
399
Methods Citations
29
Results Citations
13

Figures and Tables from this paper

939 Citations

Multidisciplinary consensus of prevention, diagnosis and treatment of obesity in young and middle-aged men

The main modifiable risk factor for the development of chronic non-transmissible diseases in Mexico is obesity, and in Mexico, overweight.

Whole Genome and Exome Sequencing of Type 2 Diabetes

Next-generation sequencing enables interrogation of the full catalog of human genetic variation. To appropriately interpret these data and identify genetic risk factors for type 2 diabetes (T2D), logi

Differential expression profiles of circulating microRNAs in newborns associated to maternal pregestational overweight and obesity

The perinatal environment has a role in the establishment of altered metabolic and inflammatory responses, and could be modulated by microRNAs regulating immune and metabolic processes.

‘Omics’‐driven discoveries in prevention and treatment of type 2 diabetes

Eur J Clin Invest 2012; 42 (6): 579–588

Molecular medicine of diabetes mellitus

Investigation of DNA methylation in type 2 diabetes genetic risk loci

The author states that the use of abbreviations in this book has changed in recent years from being primarily for grammars to being more representative of the vernacular of the internet age.

Genetics of Diabetes: Are They Thrifty Genotype?

Diabetes mellitus: a “thrifty” genotype rendered detrimental by “progress” by James Neel (Am J Hum Genet 14:353–362, 1962).

Chronic tissue inflammation and metabolic disease.

In this review, Lee and Olefsky discuss the characteristics of chronic inflammation in the major metabolic tissues and how obesity triggers these events, including a focus on the role of adipose…

From genotype to human β cell phenotype and beyond

In this review, the available information on how polymorphisms in T2DM-associated genes/loci do directly affect the properties of human islet cells are presented and discussed, including some clinical implications and the role of epigenetic mechanisms.

Role of circulating levels of palmitate and palmitoleate in development of beta cell dysfunction and insulin resistance in pediatric obesity

Role of circulating levels of palmitate and palmitoleate in development of beta cell dysfunction and insulin resistance in pediatric obesity is investigated and implications for treatment of obesity and diabetes are investigated.
...

85 References

Human genetics illuminates the paths to metabolic disease

The extent to which human molecular genetic research has illuminated the understanding of their underlying pathophysiological mechanisms is explored, and type 2 diabetes and obesity are explored.

Guilt by association

Progress is reported by Bell and colleagues in their study of NIDDM1, a locus implicated in type 2 diabetes, a complex nature of the reported association illustrates the challenge of implicating a specific gene and mutation in the causation of polygenic disease.

Life Cycle of Translational Research for Medical Interventions

From the initial discovery of a medical intervention to a highly cited article is a long road, and even this is not the end of the journey.

Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: Where are the insulin resistance genes?

An up-to-date account of genetic loci that influence risk of common type 2 diabetes via impairment of beta cell function, outlines their presumed mechanisms of action, and places them in the context of gene–gene and/or gene–environment interactions.

Variation in FTO contributes to childhood obesity and severe adult obesity

It is concluded that FTO contributes to human obesity and hence may be a target for subsequent functional analyses.

Monogenic β-cell dysfunction in children: clinical phenotypes, genetic etiology and mutational pathways

The etiology of pediatric monogenic β-cell dysfunction is defined and guidance is provided on the investigation and management of children presenting with monogenicβ- cell dysfunction.

Genome-Wide Association Analysis Identifies Loci for Type 2 Diabetes and Triglyceride Levels

The discovery of associated variants in unsuspected genes and outside coding regions illustrates the ability of genome-wide association studies to provide potentially important clues to the pathogenesis of common diseases.

Inactivation of the Fto gene protects from obesity

These experiments provide the first direct demonstration that Fto is functionally involved in energy homeostasis by the control of energy expenditure, and leads to postnatal growth retardation and a significant reduction in adipose tissue and lean body mass.

Common variants in WFS1 confer risk of type 2 diabetes

Using a gene-centric approach, it is shown that variation in WFS1 also predisposes to common type 2 diabetes.

Pharmacogenetics in diabetes

    E. Pearson
    Biology, Medicine
    Current diabetes reports
  • 2009
With increasing well-phenotyped cohorts and new methods, including genome-wide association studies, the next few years offer great hope to use pharmacogenetics to unravel drug and disease mechanisms, as well as the possibility to individualize therapy by genotype.
...